| Literature DB >> 32764078 |
Katherine Wang1,2, Cathrine N Eftang3, Rune Bruhn Jakobsen4,5, Asbjørn Årøen5,6.
Abstract
OBJECTIVES: Gain an overview of expected response rates (RRs) to patient-reported outcome measures (PROMs) in clinical quality registry-based studies and long-term cohorts in order to better evaluate the validity of registries and registry-based studies. Examine the trends of RRs over time and how they vary with study type, questionnaire format, and the use of reminders.Entities:
Keywords: PROM; patient reported outcome measure; registries; response rate
Mesh:
Year: 2020 PMID: 32764078 PMCID: PMC7412618 DOI: 10.1136/bmjopen-2019-030808
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Terms used in the systematic searches
| Search 1 in PubMed | Search 2 in EMBASE and Ovid MEDLINE |
(“register” OR “registry” OR “prospective cohort” OR “prospective cohort study”) (“PROMs” OR “subjective outcome” OR “patient outcome” OR “clinical symptoms”) (“compliance” OR “response rate”) 1 and 2 and 3 | exp Registries/or exp Register/ (register* or registr*).tw. prospective cohort*.tw. 1 or 2 or 3 exp Patient Reported Outcome Measures/ or exp Patient Outcome Assessment/or exp “Outcome Assessment (Health Care)”/ or exp Patient Reported Outcome/ or exp Outcome Assessment/ or exp “Outcome and Process Assessment (Health Care)”/ patient-reported outcome.tw. PROM.tw. exp self report/ self report*.tw. exp Questionnaires/ or exp Questionnaire/ exp Survey/and Questionnaires/ subjective outcome*.tw. patient outcome*.tw. clinical symptom*.tw. response rate.tw. compliance.tw. 15 or 16 randomized controlled stud*.mp. randomized controlled trial*.mp. rct.mp 18 or 19 or 20 (retrospective or qualitative stud*).mp. 21 or 22 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 4 and 17 and 24 25 not 23 |
Included articles and annual registry reports with extracted data
| ID | Lead author (year) | Format | No of reminders | RR (%) at follow-up points | Total follow-up time (years) | Change in RR (%/year)* | ||||
| #0 | #1 | #2 | #3 | #4 | ||||||
| Database searches—prospective cohort studies | ||||||||||
| 1 | Ahmed† | Paper | 1 | 90 | 85 | 82 | 2 | −4.0 | ||
| 2 | Ashley‡ | Mix | >1 | 85 | 70 | 66 | 1.25 | −25.3 | ||
| 3 | Blanchard | ND | ND | 99 | 85 | 82 | 81 | 50 | 4 | −11.0 |
| 4 | 99 | 70 | 57 | 44 | 45 | 4 | −13.5 | |||
| 5 | Gjeilo | Paper | 1 | 100 | 89 | 89 | 82 | 5 | −3.6 | |
| 6 | Pieterse† | Paper | >1 | 86 | 81 | 2 | −5.0 | |||
| Database searches—registry-based studies | ||||||||||
| 7 | Helsten§,‡ | Mix | >1 | 62 | 71 | 1 | 9.1 | |||
| 8 | Imam‡ | Paper | >1 | 99 | 91 | 89 | 83 | 79 | 2 | −10.1 |
| 9 | Olsson | Paper | 1 | 88 | 82 | 8 | −0.7 | |||
| 10 | Porchet† | Paper | >1 | 87 | 98 | 91 | 1 | 4.0 | ||
| 11 | Simony | Paper | 1 | 100 | 84 | 1 | −15.8 | |||
| Registry articles | ||||||||||
| 12 | Bengtsson | Paper | 1 | 93 | 87 | 5 | −1.2 | |||
| 13 | Elkan¶,‡ | Paper | 1 | 78 | 73 | 62 | 2 | −8.0 | ||
| 14 | 100 | 98 | 99 | −0.6 | ||||||
| 15 | Gjertsen | Paper | 0 | 54 | 49 | 1 | −7.5 | |||
| 16 | Kvist | Mix | >1 | 66 | 50 | 48 | 48 | 5 | −3.6 | |
| 17 | 61 | 49 | 47 | 46 | −3.0 | |||||
| 18 | 72 | 40 | 47 | 38 | −6.8 | |||||
| 19 | 68 | 38 | 46 | 38 | −6.0 | |||||
| 20 | 61 | 45 | 45 | 42 | −3.8 | |||||
| 21 | 58 | 43 | 44 | 42 | −3.2 | |||||
| 22 | Lind† | Web | 0 | 46 | 31 | 1 | −15.0 | |||
| 23 | Rahr-Wagner† | Web | 0 | 33 | 27 | 1 | −6.5 | |||
| Registry reports | ||||||||||
| 24 | SweSpine†,§ | Mix | ND | 71 | 57 | 44 | 5 | −6.7 | ||
| 25 | Danish† | Web | 0 | 37 | 31 | 1 | −5.4 | |||
| 26 | Danish Hip Arthroscopy Reg | Web | >1 | 52 | 56 | 48 | 34 | 3 | −6.0 | |
| 27 | DaneSpine†,** | Paper | 1 | 83 | 73 | 59 | 5 | −5.9 | ||
| 28 | 48 | 37 | 24 | −6.0 | ||||||
| 29 | Swedish Fracture Reg †,§ | Paper | 1 | 55 | 41 | 1 | −13.7 | |||
| 30 | Swedish Hip Arthroplasty Reg†,¶ | Mix | 1 | 83 | 88 | 1 | 4.4 | |||
| 31 | Swedish Knee Ligament Reg† | Mix | 1 | 67 | 50 | 47 | 45 | 39 | 10 | −2.7 |
| 32 | 62 | 48 | 47 | 44 | 38 | −2.3 | ||||
| 33 | Norwegian Hip Fracture Reg† | Paper | 0 | 57 | 57 | 55 | 3 | −0.6 | ||
| 34 | UK National Ligament Reg | Mix | ND | 58 | 35 | 30 | 2 | −14.0 | ||
| 35 | UK National Joint Registry†,¶,§ | Paper | >1 | 42 | 44 | 0.5 | 4.3 | |||
| 36 | 100 | 75 | 61 | 84 | 3 | −5.1 | ||||
| 37 | 100 | 76 | 0.5 | −48.2 | ||||||
| 38 | New Zealand ACL-Reg†,** | Mix | >1 | 100 | 86 | 80 | 86 | 2 | −7.0 | |
| 39 | 100 | 85 | 77 | 83 | 2 | −8.5 | ||||
| 40 | Norwegian Knee Ligament Reg†,** | Paper | 1 | 62 | 58 | 59 | 10 | −0.4 | ||
Follow-up point #0 is the reported baseline time point or time of intervention as specified in the article or report. The subsequent time point intervals (#2, #3…) vary for each article or report and is not the follow-up year. Articles or reports with multiple rows represent separate subgroups with individual RRs reported within the article.
*This is calculated by taking the difference between the last and first RRs and dividing it by the number of follow-up years between the last and first reported RR to show the average change in RR per year.
†Author/registry emailed for reminders and/or format information.ID 1, Rens Kempeneers, Feb 2019 (personal communication); ID 6, Moniek ter Kuile, Feb 2019 (personal communication); ID 10, Anne Mannion, Feb 2019 (personal communication); ID 22, 23, 25, Martin Lind, Feb 2019 (personal communication); ID 27, 28, Karen H. Hansen, Feb 2019 (personal communication); ID 29, Karin Pettersson, Feb 2019 (personal communication); ID 30, Sandra Olausson, Feb 2019 (personal communication); ID 31, 32, Anna Pappas, Feb 2019 (personal communication); ID 33, Kari A. Vågstøl, Feb 2019 (personal communication); ID 35, 36, 37, Beth at NJR Helpdesk, Feb 2019 (personal communication); ID 38, 39, Charlotte Smith, Feb 2019 (personal communication); ID 40, Anne M. Fenstad, Feb 2019 (personal communication).
‡Registry emailed about RRs. ID 27, 28, Karen H. Hansen, Feb 2019 (personal communication); ID 38, 39, Charlotte Smith, Feb 2019 (personal communication); ID 40, Anne M. Fenstad, Feb 2019 (personal communication).
§Some or all RRs calculated by author using numbers available in article or report.
¶Follow-up questionnaires only sent to previous responders.
**Change in number of PROMs or questions sent at subsequent follow-ups.
ND, not determined; PROMs, patient-reported outcome measures; RR, response rate.
Average response rates with SD for time periods
| Group | Baseline | ≤1 year | >1–2 years | >2–5 years | >5–10 years |
| All | 75±22.1 | 67±20.9 | 61±18.4 | 50±16.1 | 61±23.0 |
| Cohort | 97±4.7 | 82±7.8 | 74±11.5 | 61±18.9 | – |
| Registry | 72±21.8 | 64±21.3 | 57±18.5 | 47±13.9 | 61±23.0 |
| Paper | 86±19.4 | 75±18.6 | 71±19.4 | 60±22.1 | 76±15.3 |
| Web | 42±8.7 | 36±13.4 | 48 | 34 | – |
| Mix | 71±15.1 | 62±18.5 | 53±16.0 | 43±3.4 | 39±0.7 |
| Reminders: 0 | 39±6.7 | 41±13.3 | – | 55 | – |
| Reminders: 1 | 82±16.5 | 74±20.3 | 64±20.4 | 52±19.6 | 61±23.0 |
| Reminders: >1 | 76±20.9 | 68±18.8 | 58±17.8 | 47±15.7 | – |
If there is no SD, the average consists of only one data point.
Figure 3All response rates over time.
Figure 4Comparing response rate over time for cohort studies versus registry-based data.
Figure 5Average change in response rate per year over total follow-up time for each article and report.
Figure 6Suggested standardised terminology for registries and articles reporting rrs to PROMs. PROMs, patient-reported outcome measures.